Education
About Us
Working with TipRanks
Follow Us
Boston Scientific (BSX)
NYSE:BSX
BSX Stock Chart & Stats
$94.48
$4.44(4.82%)
At close: 4:00 PM EST
$94.48
$4.44(4.82%)
Day’s Range― - ―
52-Week Range$85.98 - $109.50
Previous CloseN/A
Volume5.49M
Average Volume (3M)8.98M
Market Cap
$137.79B
Enterprise Value$156.91B
Total Cash (Recent Filing)$534.00M
Total Debt (Recent Filing)$12.03B
Price to Earnings (P/E)50.5
Beta0.83
Next Earnings
Feb 04, 2026EPS Estimate
0.78Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.75
Shares Outstanding1,482,442,000
10 Day Avg. Volume10,567,587
30 Day Avg. Volume8,979,526
Financial Highlights & Ratios
PEG Ratio4.27
Price to Book (P/B)6.04
Price to Sales (P/S)7.85
P/FCF Ratio49.69
Enterprise Value/Market Cap1.14
Enterprise Value/Revenue8.48
Enterprise Value/Gross Profit13.42
Enterprise Value/Ebitda33.29
Forecast
1Y Price Target
$126.35Price Target Upside33.73% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering23
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Financial PerformanceManagement raised guidance, now projecting FY25 growth of ~20%, and raised adj. EPS guidance as well.
Growth PotentialBSX is expected to see strong profitable dollar growth despite competition from Medtronic in the EP market.
Product InnovationBSX's investment in a first-in-class device to treat Type 2 Diabetes has blockbuster potential.
Bears Say
Clinical TrialsOCEAN trial does not fully capture the risk of disease recurrence or progression for patients.
Reimbursement ChallengesThe lower risk population in the OCEAN trial would not have been eligible for reimbursement for a WATCHMAN device.
Trial ResultsOCEAN trial was stopped early due to a high likelihood of no difference in outcomes between its two arms.
Boston Scientific News
BSX FAQ
What was Boston Scientific’s price range in the past 12 months?
Boston Scientific lowest stock price was $85.98 and its highest was $109.50 in the past 12 months.
What is Boston Scientific’s market cap?
Boston Scientific’s market cap is $137.79B.
When is Boston Scientific’s upcoming earnings report date?
Boston Scientific’s upcoming earnings report date is Feb 04, 2026 which is in 47 days.
How were Boston Scientific’s earnings last quarter?
Boston Scientific released its earnings results on Oct 22, 2025. The company reported $0.75 earnings per share for the quarter, beating the consensus estimate of $0.714 by $0.036.
Is Boston Scientific overvalued?
According to Wall Street analysts Boston Scientific’s price is currently Undervalued.
Does Boston Scientific pay dividends?
Boston Scientific does not currently pay dividends.
What is Boston Scientific’s EPS estimate?
Boston Scientific’s EPS estimate is 0.78.
How many shares outstanding does Boston Scientific have?
Boston Scientific has 1,482,442,000 shares outstanding.
What happened to Boston Scientific’s price movement after its last earnings report?
Boston Scientific reported an EPS of $0.75 in its last earnings report, beating expectations of $0.714. Following the earnings report the stock price went up 3.954%.
Which hedge fund is a major shareholder of Boston Scientific?
Currently, no hedge funds are holding shares in BSX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Boston Scientific Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$126.35 (33.73% Upside)
$126.35 (33.73% Upside)
Blogger Sentiment
Bullish
BSX Sentiment 83%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 3.6M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▲ 0.3%
Last 30 Days ▲ 3.1%
Last 30 Days ▲ 3.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
2.75%
12-Months-Change
Fundamentals
Return on Equity
12.66%
Trailing 12-Months
Asset Growth
12.16%
Trailing 12-Months
Company Description
Boston Scientific
Boston Scientific Corporation is a global leader in the field of medical devices, specializing in innovative solutions for various medical disciplines, including cardiovascular, rhythm management, urology, and endoscopy. The company develops and manufactures a wide range of products aimed at improving patient outcomes and enhancing the quality of life for patients with complex medical conditions. Boston Scientific is dedicated to advancing the field of minimally invasive procedures and offers a diverse portfolio of devices that include stents, catheters, and surgical tools.
BSX Company Deck
BSX Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong positive outlook with significant sales and EPS growth, driven by the success of key products like WATCHMAN and EP. However, there were challenges in the EMEA region and some product lines, particularly due to operational disruptions and market-specific headwinds.View all BSX earnings summariesBSX Revenue Breakdown
35.79% MedSurg
64.22% Cardiovascular
BSX Stock 12 Month Forecast
Average Price Target
$126.35
▲(33.73% Upside)
Technical Analysis
Abbott Laboratories
―
Edwards Lifesciences
―
Medtronic
―
Stryker
―
Zimmer Biomet Holdings
―
Ownership Overview
0.16% Insiders
27.62% Mutual Funds
20.69% Other Institutional Investors
30.22% Public Companies and Individual Investors